🇺🇸 Seasonal trivalent influenza vaccine, VAXIGRIP in United States

Seasonal trivalent influenza vaccine, VAXIGRIP (Seasonal trivalent influenza vaccine, VAXIGRIP) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Seasonal trivalent influenza vaccine, VAXIGRIP in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Seasonal trivalent influenza vaccine, VAXIGRIP approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Seasonal trivalent influenza vaccine, VAXIGRIP in United States?

Center for Disease Prevention and Control of Beijing Military Region is the originator. The local marketing authorisation holder may differ — check the official source linked above.